Search
for
Sort by
Research 61–90 of 1000+
- The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Vitiligo—Current Treatment Options and Future Perspectives
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Inflammatory Skin Disease in Latin America: Treatment Challenges and Opportunities
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- ONKOLOGIA OKULISTYCZNA WCZORAJ I DZIŚ
- Androgenetska alopecija u žena
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Evaluating Scarring Alopecia Therapies from the Patient Perspective: Knowledge, Barriers to Care, and Treatment Satisfaction
- POSTĘP W DIAGNOZIE I LECZENIU STWARDNIENIA ROZSIANEGO
- Microneedling with topical administration of bleomycin as a treatment method for plantar warts
- Wide range applications of botulinum toxin in medicine - literature review
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Ophthalmic manifestations of Demodex spp. infection – what should a dermatologist know?
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Real-world Burden of Disease and Clinical Characteristics of Alopecia Areata Among Adults in Brazil: Results from a Cross-sectional Survey
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Abstracts from the 2024 WDS Forum - virtual option
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- PŁYNY- NIE ZA DUŻO, NIE ZA MAŁO, LECZ W SAM RAZ